Osang Healthcare Co.,Ltd (KOSDAQ:036220)

South Korea · Delayed Price · Currency is KRW

7,240.00

-80.00 (-1.09%)

Aug 12, 2026, 3:30 PM KST

Osang Healthcare Co.,Ltd Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	119,376	128,629	80,488	355,847	193,893	132,327
Revenue Growth	29.85%	59.81%	-77.38%	83.53%	46.53%	-48.70%
Gross Profit	49,504	57,145	25,570	221,108	98,033	47,617
Operating Income	-6,029	2,427	-24,566	142,339	49,255	-7,106
Net Income	-4,432	3,109	-11,364	116,436	40,647	1,460
Earnings Per Share	-322.15	225.69	-837.00	8921.00	3168.00	118.75
EPS Growth	-	-	-	181.60%	2567.89%	-98.76%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	38,499	41,817	10,412	143,734	61,140	47,183
Total Debt	48,566	44,306	940.33	697.8	711.81	598.89
Net Cash (Debt)	-10,067	-2,488	9,471	143,036	60,428	46,584
Net Cash Growth	-	-	-93.38%	136.71%	29.72%	-30.61%
Net Cash Per Share	-731.82	-180.62	697.57	10958.90	4707.82	3787.67

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	13,862	6,213	-38,767	152,596	42,353	10,807
Capital Expenditures	-15,908	-16,094	-27,810	-35,703	-11,702	-9,040
Free Cash Flow	-2,046	-9,881	-66,577	116,893	30,651	1,768
Free Cash Flow Growth	-	-	-	281.36%	1634.00%	-98.11%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	41.47%	44.43%	31.77%	62.14%	50.56%	35.98%
Operating Margin	-5.05%	1.89%	-30.52%	40.00%	25.40%	-5.37%
Pretax Margin	-4.24%	1.97%	-28.64%	42.84%	26.74%	0.03%
Profit Margin	-3.71%	2.42%	-14.12%	32.72%	20.96%	1.10%
FCF Margin	-1.71%	-7.68%	-82.72%	32.85%	15.81%	1.34%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	500.000	-	-	-	-	-
Dividend Per Share Growth	0%	-	-	-	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	52.37	-	-	-	-
PS Ratio	0.82	1.27	1.94	-	-	-